Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Return
35.69%
This Quarter Return
+8.9%
1 Year Return
+35.69%
3 Year Return
+149.71%
5 Year Return
+223.91%
10 Year Return
+784.38%
AUM
$14.2B
AUM Growth
+$847M
(+6.3%)
Cap. Flow
-$112M
Cap. Flow
% of AUM
-0.79%
Top 10 Holdings %
Top 10 Hldgs %
19.5%
Holding
276
New
33
Increased
93
Reduced
113
Closed
27
Top Buys
| 1 |
Conagra Brands
CAG
|
$118M |
| 2 |
Netflix
NFLX
|
$107M |
| 3 |
Charter Communications
CHTR
|
$104M |
| 4 |
Wells Fargo
WFC
|
$98.7M |
| 5 |
Nike
NKE
|
$81.7M |
Top Sells
| 1 |
Constellation Brands
STZ
|
$109M |
| 2 |
DuPont de Nemours
DD
|
$109M |
| 3 |
Broadcom
AVGO
|
$105M |
| 4 |
Meta Platforms (Facebook)
META
|
$104M |
| 5 |
Comerica
CMA
|
$92.6M |
Sector Composition
| 1 | Technology | 21.28% |
| 2 | Healthcare | 16.57% |
| 3 | Industrials | 13.2% |
| 4 | Consumer Discretionary | 12.77% |
| 5 | Financials | 11.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
National Vision
EYE
$1.86B
| $21.4M | 0.15% |
474,625
-14,770
| -3% | -$667K |
|
|
WMGI
177
DELISTED
Wright Medical Group Inc
WMGI
| $20.9M | 0.15% |
720,576
-222,405
| -24% | -$6.45M |
|
178
WNS Holdings
WNS
$3.24B
| $20.7M | 0.15% |
408,595
+14,995
| +4% | +$761K |
|
179
Watsco
WSO
$16.6B
| $20.4M | 0.14% |
114,290
-995
| -0.9% | -$177K |
|
180
Advanced Energy
AEIS
$5.8B
| $19.9M | 0.14% |
386,003
-4,870
| -1% | -$252K |
|
181
DexCom
DXCM
$31.6B
| $19.7M | 0.14% |
+551,168
| New | +$19.7M |
|
182
Arista Networks
ANET
$180B
| $19.3M | 0.14% |
+1,160,336
| New | +$19.3M |
|
|
CLVS
183
DELISTED
Clovis Oncology, Inc.
CLVS
| $19.2M | 0.13% |
653,658
-148,410
| -19% | -$4.36M |
|
|
CORV
184
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $19.2M | 0.13% |
4,774,149
+146,195
| +3% | +$588K |
|
185
Lincoln Electric
LECO
$13.5B
| $19.2M | 0.13% |
+204,980
| New | +$19.2M |
|
186
H.B. Fuller
FUL
$3.37B
| $18M | 0.13% |
348,794
-136,246
| -28% | -$7.04M |
|
187
Nektar Therapeutics
NKTR
$764M
| $16.2M | 0.11% |
17,684
-30,386
| -63% | -$27.8M |
|
188
Sarepta Therapeutics
SRPT
$1.96B
| $15.3M | 0.11% |
+94,655
| New | +$15.3M |
|
189
Alnylam Pharmaceuticals
ALNY
$59.2B
| $15M | 0.11% |
170,855
-57,285
| -25% | -$5.01M |
|
|
XENT
190
DELISTED
Intersect ENT, Inc
XENT
| $13.6M | 0.1% |
474,282
+12,750
| +3% | +$367K |
|
191
Fate Therapeutics
FATE
$116M
| $13.6M | 0.1% |
832,070
+26,610
| +3% | +$433K |
|
192
Viavi Solutions
VIAV
$2.6B
| $13.3M | 0.09% |
+1,175,395
| New | +$13.3M |
|
193
FibroGen
FGEN
$48.9M
| $12.7M | 0.09% |
8,383
-84
| -1% | -$128K |
|
194
Ultra Clean Holdings
UCTT
$1.11B
| $12.7M | 0.09% |
1,011,698
+121,415
| +14% | +$1.52M |
|
195
Evolent Health
EVH
$1.11B
| $11.8M | 0.08% |
+416,980
| New | +$11.8M |
|
196
Apellis Pharmaceuticals
APLS
$3.55B
| $10.9M | 0.08% |
612,296
+5,340
| +0.9% | +$94.9K |
|
197
Floor & Decor
FND
$9.42B
| $10.8M | 0.08% |
358,246
-145,945
| -29% | -$4.4M |
|
198
NovoCure
NVCR
$1.37B
| $10.8M | 0.08% |
205,805
-303,805
| -60% | -$15.9M |
|
|
NEWR
199
DELISTED
New Relic, Inc.
NEWR
| $10.7M | 0.08% |
114,074
-114,040
| -50% | -$10.7M |
|
200
Camden Property Trust
CPT
$11.9B
| $10.5M | 0.07% |
111,931
-125,564
| -53% | -$11.7M |
|